» Articles » PMID: 15863643

Activation of Human Lung Mast Cells by Monomeric Immunoglobulin E

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2005 May 3
PMID 15863643
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of chronic mast cell activation in asthma is unclear. Monomeric immunoglobulin (Ig)E in the absence of allergen induces mediator release from rodent mast cells, indicating a possible role for IgE in the continued activation of mast cells within the asthmatic bronchial mucosa. In this study it was investigated whether monomeric IgE induces Ca2+ influx and mediator release from human lung mast cells (HLMC). Purified HLMC were cultured for 4 weeks and then exposed to monomeric human myeloma IgE. Ratiometric Ca2+ imaging was performed on single fura-2-loaded cells. Histamine release was measured by radioenzymatic assay; leukotriene C4 (LTC4) and interleukin (IL)-8 were measured by ELISA. At concentrations experienced in vivo, monomeric IgE induced dose-dependent histamine release, LTC4 production and IL-8 synthesis. This was associated with a rise in cytosolic free Ca2+. Enhanced histamine release was still evident 1 week after initial exposure to IgE suggesting that continued exposure maintains enhanced secretion. Monomeric immunoglobulin E alone activates cultured human lung mast cells initiating Ca2+ influx, degranulation, arachidonic acid metabolism and cytokine synthesis. These findings support the hypothesis that immunoglobulin E loading of mast cells within the asthmatic airway contributes to the disordered airway physiology of this disease.

Citing Articles

Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells.

Bakhashab S, Banafea G, Ahmed F, Alsolami R, Schulten H, Gauthaman K PLoS One. 2024; 19(10):e0311981.

PMID: 39432538 PMC: 11493263. DOI: 10.1371/journal.pone.0311981.


Atopy in chronic urticaria: an important yet overlooked issue.

Chen Q, Yang X, Ni B, Song Z Front Immunol. 2024; 15:1279976.

PMID: 38380314 PMC: 10876790. DOI: 10.3389/fimmu.2024.1279976.


Mast Cell Purification Protocols.

Farrington J, Seward E, Peachell P Methods Mol Biol. 2020; 2163:49-56.

PMID: 32766964 DOI: 10.1007/978-1-0716-0696-4_3.


Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Pelaia C, Calabrese C, Terracciano R, Blasio F, Vatrella A, Pelaia G Ther Adv Respir Dis. 2018; 12:1753466618810192.

PMID: 30400762 PMC: 6236630. DOI: 10.1177/1753466618810192.


IgE Trimers Drive SPE-7 Cytokinergic Activity.

Bax H, Bowen H, Beavil R, Chung R, Ward M, Davies A Sci Rep. 2017; 7(1):8164.

PMID: 28811536 PMC: 5557881. DOI: 10.1038/s41598-017-08212-6.